DE60221691D1 - Tamsulosin tabletten ohne nahrungsmitteleffekt - Google Patents

Tamsulosin tabletten ohne nahrungsmitteleffekt

Info

Publication number
DE60221691D1
DE60221691D1 DE60221691T DE60221691T DE60221691D1 DE 60221691 D1 DE60221691 D1 DE 60221691D1 DE 60221691 T DE60221691 T DE 60221691T DE 60221691 T DE60221691 T DE 60221691T DE 60221691 D1 DE60221691 D1 DE 60221691D1
Authority
DE
Germany
Prior art keywords
food effect
tamsulosin tablets
tamsulosin
tablets
food
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60221691T
Other languages
English (en)
Other versions
DE60221691T2 (de
DE60221691T3 (de
Inventor
Jacobus Maria Lemmens
Johannes Jan Platteeuw
Dalen Frans Van
Arturo Siles Ortega
Juan Cucala Escoi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthon BV
Original Assignee
Synthon BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23292437&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60221691(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Synthon BV filed Critical Synthon BV
Application granted granted Critical
Publication of DE60221691D1 publication Critical patent/DE60221691D1/de
Publication of DE60221691T2 publication Critical patent/DE60221691T2/de
Publication of DE60221691T3 publication Critical patent/DE60221691T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60221691.5T 2001-11-07 2002-11-06 Tamsulosin tabletten ohne nahrungsmitteleffekt Expired - Lifetime DE60221691T3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US33105501P 2001-11-07 2001-11-07
US331055P 2001-11-07
PCT/NL2002/000710 WO2003039531A1 (en) 2001-11-07 2002-11-06 Modified release tamsulosin tablets
EP02780143.0A EP1441713B2 (de) 2001-11-07 2002-11-06 Tamsulosin tabletten ohne nahrungsmitteleffekt

Publications (3)

Publication Number Publication Date
DE60221691D1 true DE60221691D1 (de) 2007-09-20
DE60221691T2 DE60221691T2 (de) 2008-04-30
DE60221691T3 DE60221691T3 (de) 2019-04-04

Family

ID=23292437

Family Applications (4)

Application Number Title Priority Date Filing Date
DE60210315T Expired - Lifetime DE60210315T2 (de) 2001-11-07 2002-11-01 Tamsulosin tabletten
DE20220415U Expired - Lifetime DE20220415U1 (de) 2001-11-07 2002-11-01 Tamsulosin-Tabletten
DE60221691.5T Expired - Lifetime DE60221691T3 (de) 2001-11-07 2002-11-06 Tamsulosin tabletten ohne nahrungsmitteleffekt
DE20221486U Expired - Lifetime DE20221486U1 (de) 2001-11-07 2002-11-06 Tamsulosin-Tabletten mit modifizierter Freisetzung

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE60210315T Expired - Lifetime DE60210315T2 (de) 2001-11-07 2002-11-01 Tamsulosin tabletten
DE20220415U Expired - Lifetime DE20220415U1 (de) 2001-11-07 2002-11-01 Tamsulosin-Tabletten

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE20221486U Expired - Lifetime DE20221486U1 (de) 2001-11-07 2002-11-06 Tamsulosin-Tabletten mit modifizierter Freisetzung

Country Status (21)

Country Link
US (2) US20030147950A1 (de)
EP (3) EP1443917B1 (de)
JP (3) JP2005512997A (de)
CN (3) CN1298317C (de)
AT (3) ATE321544T1 (de)
AU (1) AU2002301845B2 (de)
CA (2) CA2465110A1 (de)
CZ (3) CZ16814U1 (de)
DE (4) DE60210315T2 (de)
DK (3) DK1443917T3 (de)
ES (2) ES2256544T3 (de)
HU (2) HUP0401978A3 (de)
IL (4) IL161491A0 (de)
NL (2) NL1021822C2 (de)
NO (2) NO340960B1 (de)
NZ (2) NZ532589A (de)
PT (2) PT1443917E (de)
RU (2) RU2311903C2 (de)
SI (2) SI1443917T1 (de)
WO (2) WO2003039530A1 (de)
ZA (2) ZA200403281B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2311903C2 (ru) † 2001-11-07 2007-12-10 Синтон Б.В. Таблетки тамзулосина
US7018658B2 (en) * 2002-11-14 2006-03-28 Synthon Bv Pharmaceutical pellets comprising tamsulosin
IN192381B (de) * 2002-12-20 2004-04-10 Ranbaxy Lab
US20040253309A1 (en) * 2003-01-27 2004-12-16 Yamanouchi Pharmaceutical Co., Ltd. Enteric sustained-release fine particles of tamsulosin and its salt and manufacturing method thereof
WO2005004851A1 (en) * 2003-07-01 2005-01-20 Krka, Tovarna Zdravil, D.D. Novo Mesto Tamsulosin core with a coating of polyvinylpyrrolidone and polyvinylacetate
KR100762846B1 (ko) * 2003-09-29 2007-10-04 씨제이 주식회사 서방성 제제
US20070122480A1 (en) * 2003-09-29 2007-05-31 Cj Corporation Sustained release formulations
JP2005104914A (ja) * 2003-09-30 2005-04-21 Kyowa Yakuhin Kogyo Kk 塩基性薬剤含有製剤
JP2005162737A (ja) * 2003-11-10 2005-06-23 Astellas Pharma Inc 徐放性医薬組成物
US8128958B2 (en) * 2003-11-10 2012-03-06 Astellas Pharma Inc. Sustained release pharmaceutical composition
JP2005162736A (ja) * 2003-11-10 2005-06-23 Astellas Pharma Inc 徐放性医薬組成物
US8197846B2 (en) * 2003-11-10 2012-06-12 Astellas Pharma Inc. Sustained release pharmaceutical composition
AU2003286415A1 (en) * 2003-12-03 2005-06-24 Natco Pharma Limited An improved pharmaceutical formulation containing tamsulosin salt and a process for its preparation
SI21702A (en) * 2004-01-29 2005-08-31 Lek Farmacevtska Druzba Dd Preparation of amorphous form of tamsulosin
JP4603803B2 (ja) * 2004-01-30 2010-12-22 大洋薬品工業株式会社 放出制御医薬組成物およびこれを用いる製剤
PL204079B1 (pl) * 2004-08-12 2009-12-31 Inst Farmaceutyczny Stały doustny preparat chlorowodorku tamsulozyny o przedłużonym uwalnianiu i sposób jego wytwarzania
WO2006055659A2 (en) * 2004-11-15 2006-05-26 Smithkline Beecham Corporation Fixed dose combination op dutasteride and tamsulosin
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
RU2401125C2 (ru) 2004-12-27 2010-10-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Способ стабилизации лекарственного средства против деменции
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
US20060160852A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Composition containing anti-dementia drug
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
KR100678421B1 (ko) * 2005-02-11 2007-02-02 주식회사 씨티씨바이오 염산 탐스로신 함유 방출조절 제제
WO2006118265A1 (ja) * 2005-04-28 2006-11-09 Eisai R & D Management Co., Ltd. 抗痴呆薬を含有する組成物
CN1895241B (zh) * 2005-07-12 2010-05-12 可隆制药株式会社 盐酸坦洛新的口服长效性小药丸组成物及其制造方法
WO2007017253A1 (de) * 2005-08-10 2007-02-15 Add Advanced Drug Delivery Technologies Ltd. Orales präparat mit kontrollierter freisetzung eines benzolsulfonamids
KR20070021806A (ko) * 2005-08-19 2007-02-23 (주)아모레퍼시픽 α1-수용체 차단제의 서방형 펠렛제제 및 이의 제조 방법
KR20070044911A (ko) * 2005-10-26 2007-05-02 주식회사 씨티씨바이오 염산 탐스로신 함유 방출조절 제제
WO2007131804A1 (en) * 2006-05-17 2007-11-22 Synthon B.V. Tablet composition with a prolonged release of tamsulosin
US20090004284A1 (en) * 2007-06-26 2009-01-01 Watson Pharmaceuticals, Inc. Controlled release tamsulosin hydrochloride formulation
EP2042169A1 (de) * 2007-09-26 2009-04-01 LEK Pharmaceuticals D.D. Tabletten zur gesteuerten Freigabe von Tamsulosinhydrochlorid und ein Verfahren für ihre Herstellung
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
US8465770B2 (en) * 2008-12-24 2013-06-18 Synthon Bv Low dose controlled release tablet
TR201802207T4 (tr) 2010-03-29 2018-03-21 Astellas Pharma Inc Kontrollü Salımlı Farmasötik Bileşim.
CA2797809A1 (en) 2010-04-30 2011-11-03 Takeda Pharmaceutical Company Limited Enteric tablet
SG194922A1 (en) * 2011-05-25 2013-12-30 Taiho Pharmaceutical Co Ltd Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
CN102579392A (zh) * 2012-03-30 2012-07-18 重庆科瑞制药(集团)有限公司 一种含有盐酸坦索罗辛的缓释制剂及其制备方法
EP3448366A1 (de) 2016-04-25 2019-03-06 Synthon B.V. Tablettenzusammensetzung aus mirabegron mit modifizierter freisetzung
CA3078568A1 (en) 2017-10-12 2019-04-18 Synthon B.V. Modified release tablet composition comprising mirabegron
EP3292864A1 (de) 2017-10-12 2018-03-14 Synthon B.V. Tablettenzusammensetzung aus mirabegron mit modifizierter freisetzung
US10478399B2 (en) 2017-10-12 2019-11-19 Synthon B.V. Modified release tablet composition comprising mirabegron
PL3697392T3 (pl) 2017-10-17 2024-03-25 Synthon B.V. Tabletki zawierające tamsulosynę i solifenacynę

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
US5391825A (en) * 1980-02-08 1995-02-21 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl substituted phenethylamine intermediates
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
DE3681348D1 (de) * 1985-06-11 1991-10-17 Teijin Ltd Oral-arzneizubereitung mit retardwirkung.
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
IE60311B1 (en) * 1987-09-24 1994-06-29 American Home Prod Sustained release etodolac
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
NZ257993A (en) * 1992-11-04 1997-05-26 Sepracor Inc Use of (+)-doxazosin and medicament containing the compound
IL109460A (en) * 1993-05-10 1998-03-10 Euro Celtique Sa Controlled release formulation comprising tramadol
EP0710486A4 (de) * 1993-07-14 1997-07-09 Yamanouchi Pharma Co Ltd Arzneimittel gegen dysfunktionen bei der harnentleerung, die in verbindung stehen mit prostatahypertrophie
US5576014A (en) * 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
US5945125A (en) * 1995-02-28 1999-08-31 Temple University Controlled release tablet
JPH09323926A (ja) * 1996-03-15 1997-12-16 Nikken Chem Co Ltd バルプロ酸ナトリウムの徐放性錠剤
AU7888298A (en) * 1997-01-03 1998-07-31 Elan Corporation, Plc Sustained release cisapride minitablet formulation
US5843472A (en) * 1997-02-28 1998-12-01 Cygnus, Inc. Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use
JP4221068B2 (ja) * 1997-12-17 2009-02-12 興和創薬株式会社 テオフィリン徐放性錠剤及びその製造方法
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
TW536402B (en) * 1998-06-26 2003-06-11 Yamanouchi Pharma Co Ltd Pharmaceutical composition for the therapy of voiding dysfunction
JP2000080032A (ja) * 1998-06-26 2000-03-21 Yamanouchi Pharmaceut Co Ltd 排出障害治療剤
JP2000128774A (ja) * 1998-10-26 2000-05-09 Tanabe Seiyaku Co Ltd 薬物を含有する球形微粒子の製法
US6419960B1 (en) * 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CZ300551B6 (cs) * 1999-03-31 2009-06-17 Janssen Pharmaceutica N. V. Predželatinovaný škrob v rízene se uvolnující formulaci
CA2698347A1 (en) * 1999-05-20 2000-11-30 Elan Pharma International Limited Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
EP1064938A1 (de) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmazeutische Dosierungsformen zur kontrollierte Wirkstoffabgabe mit mindenstens ein pulsierendem Zeitverlauf
TR200102583T2 (tr) * 1999-08-09 2002-07-22 Yamanouchi Pharmaceutical Co., Ltd. Alt idrar yolları semptomlarının tedavisine yönelik farmasötik bileşim.
JP3154710B1 (ja) * 1999-08-09 2001-04-09 山之内製薬株式会社 下部尿路症治療剤
GB9924020D0 (en) * 1999-10-11 1999-12-15 Pfizer Ltd Pharmaceutically active compounds
IL141235A (en) * 2000-02-09 2012-04-30 Novartis Int Pharm Ltd Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia
GB0008332D0 (en) * 2000-04-04 2000-05-24 Pfizer Ltd Treament
US6368628B1 (en) * 2000-05-26 2002-04-09 Pharma Pass Llc Sustained release pharmaceutical composition free of food effect
US6287599B1 (en) * 2000-12-20 2001-09-11 Shire Laboratories, Inc. Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
DE10109763A1 (de) * 2001-02-28 2002-09-05 Gruenenthal Gmbh Pharmazeutische Salze
ATE482692T1 (de) * 2001-07-27 2010-10-15 Astellas Pharma Inc Zusammensetzung enthaltend feine körner mit verzögerter freisetzung für in der mundhöhle schnell zerfallende tabletten
RU2311903C2 (ru) * 2001-11-07 2007-12-10 Синтон Б.В. Таблетки тамзулосина

Also Published As

Publication number Publication date
NZ532589A (en) 2005-02-25
NL1021822A1 (nl) 2003-05-08
CN1589139A (zh) 2005-03-02
CN102327250A (zh) 2012-01-25
ES2287333T3 (es) 2007-12-16
DK200500297U3 (da) 2006-03-10
NO20042375L (no) 2004-08-09
EP1441713B2 (de) 2018-11-14
RU2335280C2 (ru) 2008-10-10
CZ16809U1 (cs) 2006-08-28
IL161491A (en) 2009-07-20
RU2004117081A (ru) 2005-03-20
ZA200403281B (en) 2005-12-13
HUP0401978A3 (en) 2008-07-28
CZ16813U1 (cs) 2006-08-28
CN1298317C (zh) 2007-02-07
NL1021857C2 (nl) 2004-01-09
EP1595538A2 (de) 2005-11-16
CN1652760A (zh) 2005-08-10
HUP0401978A2 (hu) 2005-01-28
US20030147950A1 (en) 2003-08-07
WO2003039530A1 (en) 2003-05-15
EP1595538A3 (de) 2006-02-22
ATE369128T2 (de) 2007-08-15
ES2287333T5 (es) 2019-04-29
DE60221691T2 (de) 2008-04-30
EP1443917B1 (de) 2006-03-29
NO340960B1 (no) 2017-07-31
RU2004117080A (ru) 2005-04-10
JP2011051995A (ja) 2011-03-17
DK1441713T4 (en) 2019-02-18
NL1021857A1 (nl) 2003-05-08
EP1441713B1 (de) 2007-08-08
DK1441713T3 (da) 2007-12-17
ZA200403430B (en) 2006-02-22
WO2003039531A1 (en) 2003-05-15
ATE321544T1 (de) 2006-04-15
DE60221691T3 (de) 2019-04-04
RU2311903C2 (ru) 2007-12-10
ES2256544T3 (es) 2006-07-16
DE60210315T2 (de) 2006-11-02
IL161491A0 (en) 2004-09-27
IL161525A0 (en) 2004-09-27
IL161525A (en) 2012-12-31
US20030147955A1 (en) 2003-08-07
JP5536610B2 (ja) 2014-07-02
EP1441713A1 (de) 2004-08-04
HUP0402004A3 (en) 2008-08-28
HU230830B1 (hu) 2018-07-30
AT9978U1 (de) 2008-07-15
AU2002301845B2 (en) 2008-06-05
CA2464689C (en) 2011-02-01
DE20220415U1 (de) 2003-10-09
NZ532592A (en) 2005-02-25
NO20042374L (no) 2004-08-09
EP1443917A1 (de) 2004-08-11
SI1443917T1 (sl) 2006-06-30
CZ16814U1 (cs) 2006-08-28
JP2005511591A (ja) 2005-04-28
PT1441713E (pt) 2007-08-28
SI1441713T1 (sl) 2007-10-31
DE60210315D1 (de) 2006-05-18
NL1021822C2 (nl) 2003-07-15
HUP0402004A2 (hu) 2005-01-28
DK1443917T3 (da) 2006-07-17
CA2464689A1 (en) 2003-05-15
CA2465110A1 (en) 2003-05-15
PT1443917E (pt) 2006-06-30
JP2005512997A (ja) 2005-05-12
SI1441713T2 (sl) 2019-03-29
DE20221486U1 (de) 2006-02-02

Similar Documents

Publication Publication Date Title
DE60221691D1 (de) Tamsulosin tabletten ohne nahrungsmitteleffekt
DE60204695D1 (de) Entsafter
DE60226103D1 (de) Heilnahrungsmittel
DE60201274D1 (de) Fritiergerät
NO20042502L (no) Farmasoytisk formulering omfattende bicalutamid
NO20033324L (no) Anti-stressmiddel
DE10107471B4 (de) Vitrine
NO20012945D0 (no) Fat
FI20012292A0 (fi) Kasvisvalmiste
FIU20010234U0 (fi) Pasta-tuote
UA5643S (uk) Хлібні горішки
ES1048195Y (es) Caramelo grotesco
ITGE20010036A0 (it) Tostapane
FI5009U1 (fi) Tabletti
ITRG20010002U1 (it) Cream karrua
ATA14612001A (de) Portioniervorrichtung
UA5680S (uk) Кукурудзяні вироби
ES1049209Y (es) Barbacoa
UA5806S (uk) Кондитерський виріб
UA7000S (uk) Борошняні солодощі
ITTS20010019A1 (it) Apparecchio sgusciauova
UY3355Q (es) Caramelo
FI20001002A0 (fi) Pastatuotteet
CA93648S (fr) Fauteuil
UA7139S (uk) Борошняні солодощі (сушка)

Legal Events

Date Code Title Description
8363 Opposition against the patent